ATOSSA THERAPEUTICS, INC.
ATOS$544M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSEATTLE15 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
ATOS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
(Z)-endoxifen | Phase 2 | Breast Neoplasms | - | - |
Topical endoxifen | Phase 2 | Mammographic Breast Density | - | - |
Breast Density
1 drug in this indication
Breast Neoplasms
1 drug in this indication
Mammographic Breast Density
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply